Literature DB >> 7909984

Localization of the gene for the nevoid basal cell carcinoma syndrome.

A M Goldstein1, C Stewart, A E Bale, S J Bale, M Dean.   

Abstract

The nevoid basal cell carcinoma syndrome (NBCC) is an autosomal dominant multisystem disorder characterized by multiple basal cell carcinomas, jaw cysts, pits of the palms and/or soles, ectopic calcification, and skeletal malformations. The NBCC gene has recently been mapped to chromosome 9q22.3-9q31. In order to further define the region containing the NBCC gene, we have analyzed 137 individuals from eight families for linkage, using 11 markers from the region. Eight markers showed statistically significant evidence for linkage to NBCC. Three markers (D9S180, ALDOB, and D9S173) showed no definite recombination with the disease locus. All families showed some evidence for linkage to markers in this region. On the basis of the inspection of individual recombinants and previously published information about map location, we suggest the following order for the markers: D9S119-D9S12-D9S197-D9S196-(NBCC,D9S180 -D9S173,ALDOB)-D9S109- D9S127-(D9S53,D9S29). We are currently developing YAC contigs for the most closely linked markers, to further refine the location of the NBCC gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7909984      PMCID: PMC1918262     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Localisation of gene for the naevoid basal-cell carcinoma syndrome.

Authors:  A Reis; W Küster; G Linss; E Gebel; H Hamm; W Fuhrmann; G Wolff; W Groth; G Gustafson; M Kuklik
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

2.  Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome.

Authors:  R J GORLIN; R W GOLTZ
Journal:  N Engl J Med       Date:  1960-05-05       Impact factor: 91.245

3.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

4.  The nevoid basal cell carcinoma syndrome.

Authors:  D E Anderson; W B Taylor; H F Falls; R T Davidson
Journal:  Am J Hum Genet       Date:  1967-01       Impact factor: 11.025

5.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

Review 6.  Nevoid basal-cell carcinoma syndrome.

Authors:  R J Gorlin
Journal:  Medicine (Baltimore)       Date:  1987-03       Impact factor: 1.889

7.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

8.  Developmental defects in Gorlin syndrome related to a putative tumor suppressor gene on chromosome 9.

Authors:  M R Gailani; S J Bale; D J Leffell; J J DiGiovanna; G L Peck; S Poliak; M A Drum; B Pastakia; O W McBride; R Kase
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

9.  Location of gene for Gorlin syndrome.

Authors:  P A Farndon; R G Del Mastro; D G Evans; M W Kilpatrick
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

Review 10.  The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma.

Authors:  D G Evans; P A Farndon; L D Burnell; H R Gattamaneni; J M Birch
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more
  9 in total

1.  Molecular analysis of medulloblastomas occurring simultaneously in monozygotic twins.

Authors:  W Scheurlen; N Sörensen; W Roggendorf; J Kühl
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

2.  Basal cell nevus syndrome showing several histologic types of Basal cell carcinoma.

Authors:  Jae Wan Go; Shin Han Kim; Sang Yeop Yi; Han Kyoung Cho
Journal:  Ann Dermatol       Date:  2011-09-30       Impact factor: 1.444

Review 3.  DNA copy number losses in human neoplasms.

Authors:  S Knuutila; Y Aalto; K Autio; A M Björkqvist; W El-Rifai; S Hemmer; T Huhta; E Kettunen; S Kiuru-Kuhlefelt; M L Larramendy; T Lushnikova; O Monni; H Pere; J Tapper; M Tarkkanen; A Varis; V M Wasenius; M Wolf; Y Zhu
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

4.  The occurrence of endometrial adenocarcinoma in a patient with basal cell nevus syndrome.

Authors:  M A Khalifa; G Patterson-Cobbs; C H Hansen; J F Hines; J C Johnson
Journal:  J Natl Med Assoc       Date:  1997-08       Impact factor: 1.798

5.  Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas.

Authors:  D Schofield; D C West; D C Anthony; R Marshal; J Sklar
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

6.  Analysis of mutation in exon 17 of PTCH in patients with nevoid basal cell carcinoma syndrome.

Authors:  Jichen Li; Jinhui Wang; Yingqun Liu; Wei Wang
Journal:  Mol Biol Rep       Date:  2010-01       Impact factor: 2.316

7.  No evidence of mutation in the human PTC gene, responsible for nevoid basal cell carcinoma syndrome, in human primary squamous cell carcinomas of the esophagus and lung.

Authors:  K Suzuki; Y Daigo; S Fukuda; T Tokino; M Isomura; K Isono; B Wainwright; Y Nakamura
Journal:  Jpn J Cancer Res       Date:  1997-03

8.  Whole-exome sequencing of nevoid basal cell carcinoma syndrome families and review of Human Gene Mutation Database PTCH1 mutation data.

Authors:  D Matthew Gianferante; Melissa Rotunno; Michael Dean; Weiyin Zhou; Belynda D Hicks; Kathleen Wyatt; Kristine Jones; Mingyi Wang; Bin Zhu; Alisa M Goldstein; Lisa Mirabello
Journal:  Mol Genet Genomic Med       Date:  2018-11-08       Impact factor: 2.183

9.  Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer.

Authors:  E Holmberg; B L Rozell; R Toftgård
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.